Literature DB >> 15453984

Inaccurate early assessment of neurological severity in head injury.

Nino Stocchetti1, Francesca Pagan, Emiliana Calappi, Katia Canavesi, Luigi Beretta, Giuseppe Citerio, Manuela Cormio, Angelo Colombo.   

Abstract

Intubation, which requires sedation and myorelaxants, may lead to inaccurate neurological evaluation of severely head-injured patients. Aims of this study were to describe the early clinical evolution of traumatic brain injured (TBI) patients admitted to intensive care unit (ICU), to identify cases of over-estimated neurological severity, and to quantify the risk factors for this over-estimation. A total of 753 TBI patients consecutively admitted to ICU of three academic neurosurgical hospitals (NSH) were assessed. Cases whose severity was potentially over-estimated were identified by four criteria and indicated as "mistakenly severe" (MS): (1) no surgical intracranial masses; (2) could not follow commands at neurological assessment; (3) were dismissed from the ICU in < or =3 days to a regular ward; and (4) had regained the ability to obey commands. A total of 675 patients were intubated and/or sedated-paralyzed at the post-stabilization evaluation. In all, 304 patients had surgically treated intracranial masses. Among the 449 non-surgical cases, 58 patients fulfilling the criteria for MS were identified. The main features distinguishing MS from truly severe cases were younger age, higher Glasgow Coma Scale (GCS) score at all time points, Marshall classification of Computerized Tomographic (CT) scan mostly Diffuse Injury I and II, fewer pupillary abnormalities, and a lower frequency of hypoxia, hypotension, and extra-cranial injuries. In a certain proportion of non-surgical TBI patients, mostly intubated and sedated, neurological examination is difficult and severity can be over-estimated. Risk factors for this inaccurate evaluation can be identified, and clinical decisions should be based on further examination.

Entities:  

Mesh:

Year:  2004        PMID: 15453984     DOI: 10.1089/neu.2004.21.1131

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  34 in total

1.  Common data elements for pediatric traumatic brain injury: recommendations from the working group on demographics and clinical assessment.

Authors:  P David Adelson; Jose Pineda; Michael J Bell; Nicholas S Abend; Rachel P Berger; Christopher C Giza; Gillian Hotz; Mark S Wainwright
Journal:  J Neurotrauma       Date:  2011-11-07       Impact factor: 5.269

Review 2.  Blood-based diagnostics of traumatic brain injuries.

Authors:  Stefania Mondello; Uwe Muller; Andreas Jeromin; Jackson Streeter; Ronald L Hayes; Kevin K W Wang
Journal:  Expert Rev Mol Diagn       Date:  2011-01       Impact factor: 5.225

3.  Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury.

Authors:  Linda Papa; Linnet Akinyi; Ming Cheng Liu; Jose A Pineda; Joseph J Tepas; Monika W Oli; Wenrong Zheng; Gillian Robinson; Steven A Robicsek; Andrea Gabrielli; Shelley C Heaton; H Julia Hannay; Jason A Demery; Gretchen M Brophy; Joe Layon; Claudia S Robertson; Ronald L Hayes; Kevin K W Wang
Journal:  Crit Care Med       Date:  2010-01       Impact factor: 7.598

4.  Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury.

Authors:  Stefania Mondello; Akinyi Linnet; Andras Buki; Steven Robicsek; Andrea Gabrielli; Joseph Tepas; Linda Papa; Gretchen M Brophy; Frank Tortella; Ronald L Hayes; Kevin K Wang
Journal:  Neurosurgery       Date:  2012-03       Impact factor: 4.654

Review 5.  Moderate Traumatic Brain Injury: The Grey Zone of Neurotrauma.

Authors:  Daniel Agustín Godoy; Andrés Rubiano; Alejandro A Rabinstein; Ross Bullock; Juan Sahuquillo
Journal:  Neurocrit Care       Date:  2016-10       Impact factor: 3.210

6.  Glasgow coma scale motor score and pupillary reaction to predict six-month mortality in patients with traumatic brain injury: comparison of field and admission assessment.

Authors:  Marek Majdan; Ewout W Steyerberg; Daan Nieboer; Walter Mauritz; Martin Rusnak; Hester F Lingsma
Journal:  J Neurotrauma       Date:  2014-11-24       Impact factor: 5.269

7.  Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging.

Authors:  Paul J McMahon; David M Panczykowski; John K Yue; Ava M Puccio; Tomoo Inoue; Marco D Sorani; Hester F Lingsma; Andrew I R Maas; Alex B Valadka; Esther L Yuh; Pratik Mukherjee; Geoffrey T Manley; David O Okonkwo
Journal:  J Neurotrauma       Date:  2015-01-26       Impact factor: 5.269

8.  Point-of-Care Platform Blood Biomarker Testing of Glial Fibrillary Acidic Protein versus S100 Calcium-Binding Protein B for Prediction of Traumatic Brain Injuries: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study.

Authors:  David O Okonkwo; Ross C Puffer; Ava M Puccio; Esther L Yuh; John K Yue; Ramon Diaz-Arrastia; Frederick K Korley; Kevin K W Wang; Xiaoying Sun; Sabrina R Taylor; Pratik Mukherjee; Amy J Markowitz; Sonia Jain; Geoffrey T Manley
Journal:  J Neurotrauma       Date:  2020-09-14       Impact factor: 5.269

Review 9.  [Traumatic brain injury: impact on timing and modality of fracture care].

Authors:  P F Stahel; W Ertel; C E Heyde
Journal:  Orthopade       Date:  2005-09       Impact factor: 1.087

10.  Classification of traumatic brain injury for targeted therapies.

Authors:  Kathryn E Saatman; Ann-Christine Duhaime; Ross Bullock; Andrew I R Maas; Alex Valadka; Geoffrey T Manley
Journal:  J Neurotrauma       Date:  2008-07       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.